Inhibition of N-methyl-N-nitrosourea- and 7,12-dimethylbenz[a] anthracene-induced rat mammary tumorigenesis by dietary cholesterol is independent of Ha-ras mutations

Carcinogenesis

Volumn 21, Issue 4, 2000, Pages 827-831

  El Sohemy, Ahmed ^a   Archer, Michael C ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; DIMETHYLBENZ[A]ANTHRACENE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; ISOPRENOID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHYLNITROSOUREA; MEVALONIC ACID; RAS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOGENESIS; CHOLESTEROL INTAKE; CODON; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; GENE MUTATION; NONHUMAN; ONCOGENE RAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT;

EID: 0034091677     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.4.827     Document Type: Article

References (52)

1. Welsch, C.W. (1992) Relationship between dietary fat and experimental mammary tumorigenesis: a review and critique. Cancer Res., 52 (suppl.), 2040s-2048s.
2. Fay, M.P., Freedman, L.S., Clifford, C.K. and Midthune, D.N. (1997) Effect of different types and amounts of fat on the development of mammary tumors in rodents: a review. Cancer Res., 57, 3979-3988.
3. Archer, M.C., El-Sohemy, A., Stephen, L.L. and Badawi, A.F. (1997) Molecular studies on the role of dietary fat and cholesterol in breast cancer induction. Adv. Exp. Med. Biol., 422, 39-46.
4. El-Sohemy, A., Bruce, W.R. and Archer, M.C. (1996) Inhibition of rat mammary tumorigenesis by dietary cholesterol. Carcinogenesis, 17, 159-162.
5. Brown, M.S. and Goldstein, J.L. (1986) A receptor-mediated pathway for cholesterol homeostasis. Science, 232, 34-47.
6. Quesney-Huneeus, V.R., Wiley, M.H. and Siperstein, M.D. (1979) Essential role for mevalonate synthesis in DNA replication. Proc. Natl Acad. Sci. USA, 76, 5056-5060.
7. Brown, M.S. and Goldstein, J.L. (1980) Multivalent feedback regulation of HMG CoA reductase: a control mechanism coordinating isoprenoid synthesis and cell growth. J. Lipid Res., 21, 505-517.
8. Inano, H., Suzuki, K., Onoda, M. and Wakabayashi, K. (1997) Anti-carcinogenic activity of simvastatin during the promotion phase of radiation-induced mammary tumorigenesis of rats. Carcinogenesis, 18, 1723-1727.
9. Alonso, D.F., Farina, H.G., Skilton, G., Gabri, M.R., De Lorenzo, M.S. and Gomez, D.E. (1998) Reduction of mouse mammary tumor formation and metastasis by lovastatin, an inhibitor of the mevalonate pathway of cholesterol synthesis. Br. Cancer Res. Treat., 50, 83-93.
10. Wejde, J., Carlberg, M., Hjertman, M. and Larsson, O. (1993) Isoprenoid regulation of cell growth: identification of mevalonte-labelled compounds inducing DNA synthesis in human breast cancer cells depleted of serum and mevalonate. J. Cell. Physiol., 155, 539-548.
11. Larsson, O. (1994) Effects of isoprenoids on growth of normal human mammary epithelial cells and breast cancer cells in vitro. Anticancer Res., 14, 123-128.
12. Habenicht, A.J.R., Glomset, J. A. and Ross, R. (1980) Relation of cholesterol and mevalonic acid to the cell cycle in smooth muscle and swiss 3T3 cells stimulated to divide by platelet-derived growth factor. J. Biol. Chem., 255, 5134-5140.
13. Barbacid, M. (1987) ras genes. Annu. Rev. Biochem., 56, 779-827.
14. Bos, J.L. (1989) ras oncogenes in human cancer: a review. Cancer Res., 49, 4682-4689.
15. Lowy, D.R. and Willumsen, B.M. (1993) Function and regulation of ras. Annu. Rev. Biochem., 62, 851-891.
16. Gelb, M.H. (1997) Protein prenylation, et cetera: signal transduction in two dimensions. Science, 275, 1750-1751.
17. Goldstein, J.L. and Brown, M.S. (1990) Regulation of the mevalonate pathway. Nature. 343, 425-430.
18. Kohl, N.E., Mosser, S.D., deSolms, J., Giuliani, E.A., Pompliano, D.L., Graham, S.L., Smith, R.L., Scolnick, E.M., Oliff, A. and Gibbs, J.B. (1993) Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor. Science, 260, 1934-1937.
19. Kothapalli, R., Guthrie, N., Chambers, A.F. and Carroll, K.K. (1993) Farnesylamine: an inhibitor of farnesylation and growth of ras-transformed cells. Lipids, 28, 969-973.
20. Kohl, N.E., Omer, C.A., Conner, M.W., Anthony, N.J., Davide, J.P., DeSolms, S.J., Giuliani, E.A., Gomez, R.P., Graham, S.L., Hamilton, K., Handt, L.K., Hartman, G.D., Koblan, K.S., Kral, A.M., Miller, P.J., Mosser, S.D., O'Neil, T.J., Rands, E., Schaber, S.D., Gibbs, J.B. and Oliff, A. (1995) Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice. Nature Med., 1, 792-797.
21. Hara, M. and Han, M. (1995) Ras farnesyltransferase inhibitors suppress the phenotype resulting from an activated ras mutation in Caenorhabditis elegans. Proc. Natl Acad. Sci. USA, 92, 3333-3337.
22. Rogers, A.E. and Lee, S.Y. (1988) Chemically-induced mammary gland tumors in rats: modulation by dietary fat. In Ip, C., Birt, D.F., Rogers, A.E. and Mettlin, M. (eds) Dietary Fat and Cancer. Alan R. Liss, New York, NY, pp. 255-269.
23. Zarbl, H., Sukumar, S., Arthur, A.V., Martin-Zanca, D. and Barbacid, M. (1985) Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats. Nature, 315, 382-385.
24. Sukumar, S., Notario, V., Martin-Zanca, D. and Barbacid, M. (1983) Induction of mammary carcinomas in rats by nitroso-methylurea involves malignant activation of H-ras-1-locus by single point mutations. Nature. 3116, 658-661.
25. Kito, K., Kihana, T., Sugita, A., Murao, S., Akehi, S., Sato, M., Tachibana, M., Kimura, S. and Ueda, N. (1996) Incidence of p53 and Ha-ras gene mutations in chemically induced rat mammary carcinomas. Mol. Carcinog., 17, 78-83.
26. Cox, A.D. and Der, C.J. (1992) The ras/cholesterol connection: implications for ras oncogenicity. Crit. Rev. Oncog., 3, 365-400.
27. Reeves, P.G., Nielsen, F.H. and Fahey, G.C.J. (1993) AIN-93G purified diets for laboratory rodents: final report of the American Institute of Nutrition ad Hoc Writing Committee on the Reformulation of the AIN-76A Rodent Diet. J. Nutr. 123, 1939-1951.
28. Thompson, H.J., Adlakha, H. and Singh, M. (1992) Effect of carcinogen dose and age at administration on induction of mammary carcinogenesis by 1-methyl-1-nitrosourea. Carcinogenesis, 13, 1535-1539.
29. El-Sohemy, A. and Archer, M.C. (1999) Regulation of mevalonate synthesis in LDL receptor knockout mice fed n-3 or n-6 polyunsaturated fatty acids. Lipids, 34, 1037-1043.
30. Kumar, R. and Barbacid, M. (1988) Oncogene detection at the single cell level. Oncogene, 3, 647-651.
31. Ruta, M., Wolford, R., Dhar, R., Deteo-Jones, D., Ellis, R.W. and Scolnick, E.M. (1986) Nucleotide sequence of the two rat cellular rasH genes. Mol. Cell. Biol., 6, 1706-1710.
32. Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd Edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
33. Lu, S.-J. and Archer, M.C. (1992) Ha-ras activation in mammary glands of N-methyl-N-nitrosurea-treated rats genetically resistant to mammary adenocarcinogenesis. Proc. Natl Acad. Sci. USA, 89, 1001-1005.
34. De Clue, J.E., Vass, W.C., Papageorge, A.G., Lowy, D.R. and Willumsen, B.M. (1990) Inhibition of cell growth by lovastatin is independent of ras function. Cancer Res., 51, 712-717.
35. Gould, M.N., Moore, C.J., Zhang, R., Wang, B., Kennan, W.S. and Haag, J.D. (1994) Limonene chemoprevention of mammary carcinoma induction following direct in situ transfer of v-Ha-ras. Cancer Res., 54, 3540-3543.
36. Ip, C., Jiang, C., Thompson, H.J. and Scimeca, J.A. (1997) Retention of conjugated linoleic acid in the mammary gland is associated with tumor inhibition during the post-initiation phase of carcinogenesis. Carcinogenesis, 18, 755-759.
37. Ronai, Z., Lau, Y. and Cohen, L.A. (1991) Dietary N-3 fatty acids do not affect induction of Ha-ras mutations in mammary glands of NMU-treated rats. Mol. Carcinog., 4, 120-128.
38. Zhang, R., Haag, J.D. and Gould, M.N. (1990) Reduction in the frequency of activated ras oncogenes in rat mammary carcinomas with increasing N-methyl-N-nitrosourea doses or increasing prolactin levels. Cancer Res., 50, 4286-4290.
39. Singh, M., Lu, J.X., Briggs, S., McGinley, J., Haegele, A. and Thompson, H.J. (1994) Effects of excess dietary iron on the promotional stage of 1-methyl-1-nitrosourea-induced mammary carcinogenesis: pathogenetic characteristics and distribution of iron. Carcinogenesis, 15, 1567-1570.
40. Lu, J., Jiang, C., Fontaine, S. and Thompson, H.J. (1995) ras may mediate mammary cancer promotion by high-fat. Nutr. Cancer, 23, 283-290.
41. Rao, K.N., Melhem, M.F., Gabriel, H.F., Eskander, E.D., Kazanecki, M.E. and Amenta, J.S. (1988) Lipid composition and de novo cholesterogenesis in normal and neoplastic rat mammary tissues. J. Natl Cancer Inst., 80, 1248-1253.
42. Engstrom, W. and Schofield, P.N. (1987) Expression of 3-hydroxy-3-methylglutaryl coenzyme A reductase and LDL-receptor genes in human embryonic tumors and in normal foetal tissues. Anticancer Res., 7, 337-342.
43. Siperstein, M.D. and Fagan, V.M. (1964) Deletion of cholesterol-negative feedback system in liver tumors. Cancer Res., 24, 1108-1115.
44. Siperstein, M.D. (1995) Cholesterol, cholesterogenesis and cancer. Adv. Exp. Med. Biol., 369, 155-166.
45. Nakayama, M., Ju, H.R., Sugano, M. Hirose, N., Ueki, T., Doi, F. and Eynard, A.R. (1993) Effect of dietary fat and cholesterol on dimethylbenz[a]anthracene-induced mammary tumorigenesis in Sprague-Dawley rats. Anticancer Res., 13, 691-698.
46. Smith, L.L. (1981) Distribution of Oxidation Products. Plenum Press. New York, NY.
47. Brown, M.S. and Goldstein, J.L. (1992) Koch's Postulates for cholesterol. Cell, 71, 187-188.
48. AICR (1997) Food, Nutrition and the Prevention of Cancer: A Global Perspective. American Institute for Cancer Research, Washington, DC.
49. Mendola, P., Marshall, J., Graham, S., Laughlin, R.H. and Freudenheim, J.L. (1995) Dietary correlates of fat. Nutr. Cancer, 23, 161-169.
50. Ginsberg, H.N., Karmally, W., Siddiqui, M., Holleran, S., Tall, A.R., Rumsey, S.C., Deckelbaum, R.J., Blaner, W.S. and Ramakrishnan, R. (1994) A dose-response study of the effects of dietary cholesterol on fasting and postprandial lipid and lipoprotein metabolism in healthy young men. Arterioscler. Thromb., 14, 576-586.
51. El-Sohemy, A. and Archer, M.C. (1997) Regulation of mevalonate synthesis in rat mammary glands by dietary n-3 and n-6 polyunsaturated fatty acids. Cancer Res., 57, 3685-3687.
52. Singh, J., Hamid, R. and Reddy, B.S. (1997) Dietary fat and colon cancer: modulating effect of types and amount of dietary fat on ras-p21 function during promotion and progression stages of colon cancer. Cancer Res., 57, 253-258.